ETON · Eton Pharmaceuticals, Inc. · Documents
$54.88
+0.11 (+0.20%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$1.59B
Shares
28.58M
Volume · Oct 7
774.68K
Avg daily vol (3M)
603.02K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-28 | — | |
| 10-Q | 2026-08-13 | 2026-06-30 | |
| 8-K | 2026-08-13 | — | |
| 8-K | 2026-08-05 | 2026-07-31 | |
| 8-K | 2026-08-04 | 2026-07-31 | |
| 8-K | 2026-07-29 | — | |
| 8-K | 2026-06-09 | — | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 8-K | 2026-05-19 | 2026-05-18 | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| 8-K | 2026-05-01 | — | |
| 8-K | 2026-04-27 | — | |
| DEF 14A | 2026-04-24 | 2026-06-09 | |
| 8-K | 2026-04-16 | — | |
| 8-K | 2026-04-15 | 2026-04-09 | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-03-02 | 2026-02-27 | |
| 8-K | 2026-02-25 | — | |
| 8-K | 2026-02-02 | — | |
| 8-K | 2025-12-04 | — | |
| 8-K/A | 2025-11-18 | 2024-12-19 | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-08 | — | |
| 8-K | 2025-06-27 | — | |
| 8-K | 2025-06-20 | 2025-06-13 | |
| 8-K | 2025-06-10 | — | |
| 8-K | 2025-05-28 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| 8-K | 2025-05-13 | — | |
| 8-K/A | 2025-05-02 | 2024-12-19 | |
| 8-K | 2025-04-28 | — | |
| DEF 14A | 2025-04-25 | 2025-06-10 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 10-K | 2025-03-18 | 2024-12-31 | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-18 | — | |
| 8-K | 2025-03-14 | — | |
| 8-K/A | 2025-03-07 | 2024-12-19 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-07 | — | |
| 8-K | 2025-02-06 | — | |
| 8-K | 2025-01-03 | 2024-12-31 | |
| 8-K | 2024-12-20 | 2024-12-19 | |
| 8-K | 2024-12-17 | — | |
| 8-K | 2024-12-12 | 2024-12-10 |
Showing 1–50 of 172 filings